Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUMMIT: Bone Marker Feedback on Persistence to Ibandronate
NCT00545480Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Jul 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00545480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545480.